UB-BJ-05

Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitor. IC50 human sEH 0.4 nM; mouse sEH 1.9 nM

General

Type : Piperidine, Urea derivative, Adamantyl

Chemical_Nomenclature : (2,3-dimethoxy-5,6,8,9,10,11-hexahydro-7H-5,9:7,11-dimethanobenzo[9]annulen-7-yl)-3-(1-(tetrahydro-2H-pyran-4-carbonyl)piperidin-4-yl)urea

Canonical SMILES : C1(=CC2=C(C=C1OC)C3CC4(CC2CC(C3)(C4)NC(=O)NC5CCN(CC5)C(=O)C6CCOCC6)C)OC || CC12CC3CC(C1)(CC(C2)c4c3cc(c(c4)OC)OC)NC(=O)NC5CCN(CC5)C(=O)C6CCOCC6

InChI : InChI=1S\/C30H43N3O5\/c1-29-14-20-16-30(18-29,17-21(15-29)24-13-26(37-3)25(36-2)12-23(20)24)32-28(35)31-22-4-8-33(9-5-22)27(34)19-6-10-38-11-7-19\/h12-13,19-22H,4-11,14-18H2,1-3H3,(H2,31,32,35)

InChIKey : VLPVTKWHYLFBTG-AMIQKGEKSA-N

Other name(s) : A1H8Y  ||  BDBM679459  ||  US20240182406, Example 5  ||  Compound 20


MW : 525.687

Formula : C30H43N3O5

CAS_number :

PubChem :

UniChem : VLPVTKWHYLFBTG-AMIQKGEKSA-N

Target

Families : UB-BJ-05 ligand of proteins in family
Epoxide_hydrolase

Structure :
9F1A

Protein :
human-EPHX2

References (2)

Title : Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: in vivo efficacy in a murine model of chemotherapy-induced neuropathic pain - Codony_2025_J.Enzyme.Inhib.Med.Chem_40_2574990
Author(s) : Codony S , Jora B , Santos-Caballero M , Qiu Q , Calvo-Tusell C , Escriche C , Turcu AL , Prischi F , Bartra C , Val C , Morisseau C , Perez B , Bertran-Mostazo A , Osuna S , Corpas R , Grinan-Ferre C , Galdeano C , Loza MI , Pallas M , Sanfeliu C , Hammock BD , Brea J , Feixas F , Conte MR , Cobos EJ , Vazquez S
Ref : J Enzyme Inhib Med Chem , 40 :2574990 , 2025
Abstract :
PubMedSearch : Codony_2025_J.Enzyme.Inhib.Med.Chem_40_2574990
PubMedID: 41128518
Gene_locus related to this paper: human-EPHX2

Title : Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors - Codony_2022_J.Med.Chem_65_13660
Author(s) : Codony S , Entrena JM , Calvo-Tusell C , Jora B , Gonzalez-Cano R , Osuna S , Corpas R , Morisseau C , Perez B , Barniol-Xicota M , Grinan-Ferre C , Perez C , Rodriguez-Franco MI , Martinez AL , Loza MI , Pallas M , Verhelst SHL , Sanfeliu C , Feixas F , Hammock BD , Brea J , Cobos EJ , Vazquez S
Ref : Journal of Medicinal Chemistry , 65 :13660 , 2022
Abstract :
PubMedSearch : Codony_2022_J.Med.Chem_65_13660
PubMedID: 36222708